Nonsense the trial design was not correct because the factor used did not allow for variations seen in the trial in order to be properly powered. For example, the effect size difference between the blarcamesine cohort and the placebo cohort was chosen to be too high due to variation in the investigators for the CGI and the variation in the parents or caregivers for the RSBQ given the size of the sample.